losartan has been researched along with Pancreatic Diseases in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Pancreatic Diseases: Pathological processes of the PANCREAS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uesugi, T | 1 |
| Froh, M | 1 |
| Gäbele, E | 1 |
| Isayama, F | 1 |
| Bradford, BU | 1 |
| Ikai, I | 1 |
| Yamaoka, Y | 1 |
| Arteel, GE | 1 |
1 other study available for losartan and Pancreatic Diseases
| Article | Year |
|---|---|
Contribution of angiotensin II to alcohol-induced pancreatic fibrosis in rats.
Topics: Actins; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Captopril; C | 2004 |